<DOC>
	<DOCNO>NCT02459106</DOCNO>
	<brief_summary>The purpose study examine effect fat tissue-released miRNA skeletal muscle abnormal fat tissue-released miRNA contributes insulin resistance obese individual . This information important understanding body 's sugar metabolism regulate people obese become insulin resistant likely develop type 2 diabetes .</brief_summary>
	<brief_title>Effect AT-derived miRNA Biology Insulin Sensitivity Skeletal Muscle Humans</brief_title>
	<detailed_description>Study Objectives : 1 . To establish optimize methodology measure adipose tissue miRNA release . 2 . To establish optimize methodology measure effect adipose tissue-released miRNA skeletal muscle biology insulin sensitivity . 3 . To profile adipose tissue-released miRNA lean insulin-sensitive obese insulin-resistant healthy individual . 4 . To examine effect adipose tissue-released miRNA lean insulin-sensitive individual obese insulin-resistant individual skeletal muscle biology insulin sensitivity .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Able communicate meaningfully investigator legally competent provide inform write consent 1865 year age BMI 2025 kg/m2 ( lean subject ) ; 3035 kg/m2 ( obese subject ) Stable body weight ( &lt; 3 kg change last 8 week ) homeostatic model assessment ( HOMA ) insulin resistance &lt; 2.7 lean ; homeostatic model assessment ( HOMA ) insulin resistance ≥2.7 obese Lactation pregnancy , current and/or within last 6 month , per participant 's report Female subject postmenopausal Cardiovascular disease ( unstable angina , myocardial infarction coronary revascularization within 6 month ) Liver disease ( AST ALT ( alanine aminotransferase ) &gt; 2.5 time upper limit normal ) Kidney disease ( creatinine &gt; 1.6 mg/dl ) Anemia ( hemoglobin &lt; 12 g/dl men , &lt; 11 g/dl woman ) Thyroid dysfunction ( abnormal TSH ) HbA1c ≥6.5 % Uncontrolled hypertension ( systolic BP &gt; 160 mmHg , diastolic BP &gt; 100 mmHg ) History coagulopathies History ( within last 5 year ) presence malignancy , ( skin cancer , exception melanoma , may acceptable ) Current history drug abuse alcohol abuse ( &gt; 2 drinks/day ) Prior treatment ( within last 3 month ) systemic glucocorticoid ( &gt; 2 week ) , betablockers , drug weight loss , niacin fibrates History HIV , active Hepatitis B C , Tuberculosis ( participant report ) Smoke &gt; 5 cigarette per day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>micro-RNA</keyword>
	<keyword>insulin resistance</keyword>
</DOC>